Form 4: USANA Health Sciences CFO Sells Shares
SEC Form 4 Filing
USANA Health Sciences CFO, G. Doug Iiekkings, sold 4,548 shares of common stock on May 9, 2025.
Summary
- On May 9, 2025, G. Doug Iiekkings, the Chief Financial Officer of USANA Health Sciences Inc., sold 4,548 shares of the company's common stock.
- The transaction was executed at a price of $29.609 per share.
- The sale was reported on a Form 4 filing with the Securities and Exchange Commission.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting a stock sale by a company executive. It doesn't inherently convey positive or negative sentiment, but the market may interpret insider sales in various ways.
Industry Context
Insider transactions are routinely monitored by investors as they can provide signals, though not always definitive, about a company's prospects. It's important to consider the context of the sale, such as the executive's overall holdings and any stated reasons for the transaction.
Stakeholder Impact
- Shareholders may react to the news of the CFO's stock sale, potentially impacting the stock price.
Key Dates
| Date | Description |
|---|---|
| 05/09/2025 | Date of stock sale transaction |
| 05/12/2025 | Date of signature on the report |
Keywords
USANA Health Sciences, USNA, G. Doug Iiekkings, CFO, Form 4, Stock Sale, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.